PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-26.90%
Negative revenue growth while VTLE stands at 8.19%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-35.05%
Negative gross profit growth while VTLE is at 9.35%. Joel Greenblatt would examine cost competitiveness or demand decline.
507.34%
EBIT growth above 1.5x VTLE's 39.65%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
507.34%
Operating income growth above 1.5x VTLE's 39.65%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
104.88%
Net income growth under 50% of VTLE's 1575.29%. Michael Burry would suspect the firm is falling well behind a key competitor.
105.99%
EPS growth under 50% of VTLE's 1348.28%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
105.99%
Diluted EPS growth under 50% of VTLE's 1279.31%. Michael Burry would worry about an eroding competitive position or excessive dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-44.41%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-515.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
198.69%
10Y revenue/share CAGR above 1.5x VTLE's 38.37%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-57.10%
Negative 5Y CAGR while VTLE stands at 38.37%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-60.21%
Negative 3Y CAGR while VTLE stands at 38.37%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
521.16%
10Y OCF/share CAGR above 1.5x VTLE's 18.57%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-61.07%
Negative 5Y OCF/share CAGR while VTLE is at 18.57%. Joel Greenblatt would question the firm’s operational model or cost structure.
-65.65%
Negative 3Y OCF/share CAGR while VTLE stands at 18.57%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-83.99%
Negative 10Y net income/share CAGR while VTLE is at 453.79%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-97.09%
Negative 5Y net income/share CAGR while VTLE is 453.79%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-98.73%
Negative 3Y CAGR while VTLE is 453.79%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
264.25%
Equity/share CAGR of 264.25% while VTLE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
-39.66%
Negative 5Y equity/share growth while VTLE is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-63.04%
Negative 3Y equity/share growth while VTLE is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
917.44%
Dividend/share CAGR of 917.44% while VTLE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
15.72%
Dividend/share CAGR of 15.72% while VTLE is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
-50.06%
Negative near-term dividend growth while VTLE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-2.77%
Firm’s AR is declining while VTLE shows 19.96%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-100.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-31.54%
Negative asset growth while VTLE invests at 10.50%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-48.09%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-5.08%
We’re deleveraging while VTLE stands at 22.76%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.